Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by HubbardBlvdTOon Oct 07, 2020 6:22pm
398 Views
Post# 31684216

RE:RE:Q1 2021 cannabis revenue

RE:RE:Q1 2021 cannabis revenue Several reputable analysts are also calling for Aphria to have an earnings beat so it shouldn't come as a surprise when Aphria reports on the 15th. I know someone that owns several retail stores and as such he has access to OCS data and as a retailer who owns 4 stores he is seeing a noticeable % increase in Aphria sales monthly. The monthly upward revenue trend for Aphria is our friend. It's an easy call to be honest.
<< Previous
Bullboard Posts
Next >>